ibandronic acid and Lupus Erythematosus, Systemic
ibandronic acid has been researched along with Lupus Erythematosus, Systemic in 2 studies
Research
Studies (2)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Goossens, N; Rubbia-Brandt, L; Spahr, L | 1 |
Griffith, JF; Hung, VY; Kwok, AW; Lee, KK; Lee, VW; Leung, PC; Li, EK; Li, M; Qin, L; Tam, LS; Wong, KC; Zhu, TY | 1 |
Trials
1 trial(s) available for ibandronic acid and Lupus Erythematosus, Systemic
Article | Year |
---|---|
Ibandronate increases cortical bone density in patients with systemic lupus erythematosus on long-term glucocorticoid.
Topics: Absorptiometry, Photon; Adult; Bone Density; Bone Density Conservation Agents; Diphosphonates; Double-Blind Method; Female; Fractures, Bone; Glucocorticoids; Humans; Hydroxycholecalciferols; Ibandronic Acid; Lupus Erythematosus, Systemic; Middle Aged; Osteoporosis; Prednisolone; Tomography Scanners, X-Ray Computed | 2010 |
Other Studies
1 other study(ies) available for ibandronic acid and Lupus Erythematosus, Systemic
Article | Year |
---|---|
Severe immune-mediated drug-induced liver injury linked to ibandronate: a case report.
Topics: Adrenal Cortex Hormones; Chemical and Drug Induced Liver Injury; Contraindications; Diphosphonates; Female; Humans; Hydroxychloroquine; Ibandronic Acid; Lupus Erythematosus, Systemic; Middle Aged; Osteoporosis; Steroids; Treatment Outcome; Withholding Treatment | 2013 |